Sonoma Pharmaceuticals (SNOA) Share-based Compensation (2010 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Share-based Compensation of $24000.0 in Q4 2025, down 38.46% quarter-over-quarter from $39000.0 in Q3 2025, and up 84.62% on a YoY basis from $13000.0 in Q4 2024.
Sonoma Pharmaceuticals (SNOA) Share-based Compensation (2010 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Share-based Compensation history runs 16 years deep, the most recent figure standing at $24000.0 for Q4 2025.
- In Q4 2025, Share-based Compensation rose 84.62% year-over-year to $24000.0; the TTM figure through Dec 2025 stood at $210000.0 (up 3.45% YoY), while the FY2025 annual figure was $224000.0, down 56.59% from the prior year.
- Share-based Compensation was $24000.0 for Q4 2025 at Sonoma Pharmaceuticals, down from $39000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $242000.0 in Q4 2022 to a low of $13000.0 in Q4 2024.
- Historically, Share-based Compensation has averaged $98300.0 across 5 years, with a median of $79500.0 in 2024.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation jumped 332.14% in 2022, then sank 90.71% in 2024.
- A 5-year view of Share-based Compensation shows it stood at $56000.0 in 2021, then jumped by 332.14% to $242000.0 in 2022, then tumbled by 42.15% to $140000.0 in 2023, then tumbled by 90.71% to $13000.0 in 2024, then jumped by 84.62% to $24000.0 in 2025.
- The last three Share-based Compensation figures came in at $24000.0 (Q4 2025), $39000.0 (Q3 2025), and $57000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 36.86 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | 24,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Mar 31, 2024 | 69,000.00 |
| Mar 31, 2024 | 69,000.00 |
| Dec 31, 2023 | 140,000.00 |
| Dec 31, 2023 | 140,000.00 |
| Sep 30, 2023 | 130,000.00 |
| Sep 30, 2023 | 130,000.00 |